| Targeting mRNA processing as an anticancer strategy J Desterro, P Bak-Gordon, M Carmo-Fonseca Nature Reviews Drug Discovery 19 (2), 112-129, 2020 | 176 | 2020 |
| Expression Profiling in Ovarian Cancer Reveals Coordinated Regulation of BRCA1/2 and Homologous Recombination Genes N Custódio, R Savisaar, C Carvalho, P Bak-Gordon, MI Ribeiro, J Tavares, ... Biomedicines 10 (2), 199, 2022 | 7 | 2022 |
| Splicing dysregulation in glioblastoma alters the function of cell migration‐related genes M Seong, P Bak‐Gordon, Z Liu, PD Canoll, JL Manley Glia 73 (2), 251-270, 2025 | 1 | 2025 |
| SF3B1: From core splicing factor to oncogenic driver P Bak-Gordon, JL Manley RNA, rna. 080368.124, 2025 | 1 | 2025 |
| SUGP1 loss is the sole driver of SF3B1 hotspot mutant missplicing in cancer P Xing, P Bak-Gordon, J Xie, J Zhang, Z Liu, JL Manley bioRxiv, 2025.02. 17.638713, 2025 | | 2025 |
| 45P Characterizing the impact of pathogenic BRCA mutations on tissue-specific gene expression and pre-mRNA splicing P Bak-Gordon Annals of Oncology 31, S31, 2020 | | 2020 |
